How do government regulations influence the ability to practice Chinese herbal medicine in western countries

Journal of Ethnopharmacology

Volumn 196, Issue , 2017, Pages 104-109

  Fleischer, Tom ^a   Su, Yi Chang ^a   Lin, Sunny Jui Shan ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Chinese herbal medicine; Commonly used Chinese herbs; Global regulation policies; National Health Insurance Research Database; Restricted herbs; Taiwan

Indexed keywords

ARISTOLOCHIC ACID;

ARTICLE; AUSTRALIA; CANADA; CHINESE HERB; CHINESE MEDICINE; EPHEDRA SINICA; GERMANY; GOVERNMENT REGULATION; HERBAL MEDICINE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; PRESCRIPTION; TAIWAN; UNITED KINGDOM; UNITED STATES; DRUG LEGISLATION; EUROPE; NORTH AMERICA; PHYTOTHERAPY; UTILIZATION;

AUSTRALIA; EUROPE; GOVERNMENT REGULATION; HUMANS; ISRAEL; LEGISLATION, DRUG; MEDICINE, CHINESE TRADITIONAL; NORTH AMERICA; PHYTOTHERAPY; TAIWAN;

EID: 85009069275     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.11.047     Document Type: Article

References (28)

1. Canada, H., 2015a. Natural Health Products Directorate. 〈http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/acts-lois/prodnatur/index-eng.php〉. (accessed 12.08.15).
2. Canada, H., 2015b. Traditional Chinese Medicine Ingredients (TCMI). 〈 http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=tcm〉. (accessed 14.10.15).
3. Chang, H.C., Computer Analysis of Clinical Prescriptions Database (fang yao linchuang yingyong diannao fenxi ziliaoku). 2nd ed., 2008, China Medical University, Taiwan.
4. Chen, F.P., Chen, T.J., Kung, Y.Y., Chen, Y.C., Chou, L.F., Chen, F.J., Hwang, S.J., Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv. Res., 7, 2007, 26.
5. Chen, G.H., Traditions in medicine of the Yuan dynasty (yuan dai de yiliao xisu). Zhe Jiang Acad. J., 2011, 134–139.
6. CITES, 2013. Convention on International Trade in Endangered Species website. ( accessed 21.05.13).
7. Conroy, S., McIntyre, J., Choonara, I., Stephenson, T., Drug trials in children: problems and the way forward. Br. J. Clin. Pharmacol. 49 (2000), 93–97.
8. Debelle, F.D., Vanherweghem, J.L., Nortier, J.L., Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74 (2008), 158–169.
9. EMA, 2016. Questions and answers on the European Union framework for (traditional) herbal medicinal products, including those from a 'non-European'tradition. 〈http://www.ema.europa.eu/ema/〉. (Accessed 03.10.16).
10. Fan, T.P., Deal, G., Koo, H.L., Rees, D., Sun, H., Chen, S., Dou, J.H., Makarov, V.G., Pozharitskaya, O.N., Shikov, A.N., Kim, Y.S., Huang, Y.T., Chang, Y.S., Jia, W., Dias, A., Wong, V.C., Chan, K., Future development of global regulations of Chinese herbal products. J. Ethnopharmacol. 140 (2012), 568–586.
11. FDA, 2015. Guidance for Industry - Complementary and Alternative Medicine Products and their Regulation by theFood and Drug Administration. 〈http://www.fda.gov/RegulatoryInformation/Guidances/ucm144657.htm〉. (accessed 15.10.15.
12. Gao, K., Tian, G., Ye, Q., Zhai, X., Chen, J., Liu, T., Liu, K., Zhao, J., Ding, S., Papers published from 1995 to 2012 by six Traditional Chinese Medicine universities in China: a bibliometric analysis based on science citation index. J. Tradit. Chin. Med. = Chung i tsa chih ying wen pan / Spons. All-China Assoc. Tradit. Chin. Med., Acad. Tradit. Chin. Med. 33 (2013), 832–844.
13. Ishizaki, N., Yano, T., Kawakita, K., Public status and prevalence of acupuncture in Japan. Evid.-Based Complement. Altern. Med.: eCAM 7 (2010), 493–500.
14. Kaphle, K., Wu, L.-S., Yang, N.-Y.J., Lin, J.-H., Herbal medicine Research in Taiwan. Evid.-Based Complement. Altern. Med. 3 (2006), 149–155.
15. Li, J.M., Out of Place: Travels Throughout Chinese Medicine History. 2011, Asian Culture Publishing.
16. Liao, M.C.Current situation of Chinese Medicine pharmaceutical industry in Taiwan. 〈http://lifeexplorer.pixnet.net/blog/post/30180129〉. (accessed 12.08.15).
17. Liu, X.Q., Salmon, J.W., Herbal Medicine. Regul. China, Ger., U. S. Integr. Med., 2010, 9.
18. MHRA, 2015. Guidance, Banned and restricted herbal ingredients. 〈https://www.gov.uk/government/publications/list-of-banned-or-restricted-herbal-ingredients-for-medicinal-use/banned-and-restricted-herbal-ingredients〉. (accessed 20.10.15).
19. MOH, 1982. Medicinal herbs according to pharmacists regulations; 〈http://www.health.gov.il/Subjects/PharmAndCosmetics/nedicinicalPlants/Documents/medicinalPlantsList.pdf〉. (accessed 18.10.15).
20. MOH, 2013. A list of approved herbal foodstuff. 〈http://www.health.gov.il/UNITSOFFICE/HD/PH/FCS/SUPPLEMENTS/Pages/default.aspx〉. (accessed 12.05.13).
21. MOHW, 2013a. Inspection and registration criteria for herbal products (revised, May 8th, 2012); 〈http://www.mohw.gov.tw/cht/DOCMAP/DM1_P.aspx?F_list_no=204&fod_list_no=252&doc_no=500〉, 19.10.15.
22. MOHW, 2013b. Ordinances relating to the herbal medicine industry; 〈http://www.mohw.gov.tw/CHT/DOCMAP/DM1.aspx?F_list_no=204&fod_list_no=253〉. (accessed 20.10.15).
23. NCCAOM, 2014. States with Scope of Practice for Chinese Herbology. (accessed22.10.15).
24. Office of Information Services, Executive Yuan, 2012. The Republc of China (Taiwan) - Yearbook. Executive Yuan, Taiwan, 〈http://www.ey.gov.tw/2012yearbook/index.html〉.
25. Parliament, E., 2004. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending; 〈http://eur-lex.europa.eu/legal-content/EN/ALL/?Uri=CELEX:32004L0024〉.( accessed 12.08.15).
26. Sturgeon, S., 2011. Sustainability Issues of Traditional. Chinese Herbal Medicine- Part 1: Restricted Herb and Resource; 〈https://www.mayway.com/pdfs/maywaymailers/Skye-Sturgeon-QM-Restricted-herbs-P1-10-2011.pdf〉.( accessed 20.10.15).
27. TGA, 2015. Substances that may be used in Listed medicines in Australia. 〈https://www.tga.gov.au/publication/substances-may-be-used-listed-medicines-australia〉. ( accessed 20.10.15).
28. WHO, National Policy on Traditional Medicine and Regulation of Herbal Medicines - Report of a WHO Global Survey. 2005, World Health Organization, France 〈http://apps.who.int/medicinedocs/pdf/s7916e/s7916e.pdf〉.